{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:36:44Z","timestamp":1787499404224,"version":"build-2736575974"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Roche Diagnostics K.K."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>We investigated the performance of the cobas\u00ae 6800 system and cobas SARS-CoV-2 &amp; Influenza A\/B, a fully automated molecular testing system for influenza viruses and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This enabled an assay in a batch of 96 samples in approximately 3\u00a0h.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An assay was performed using the cobas SARS-CoV-2 &amp; Influenza A\/B on the cobas 6800 system for samples collected in four facilities between November 2019 and March 2020 in our previous study. The results were compared with those obtained using the reference methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 127 samples analyzed, the cobas SARS-CoV-2 &amp; Influenza A\/B detected influenza A virus in 75 samples, of which 73 were positive using the reference methods. No false negative results were observed. The overall positive and negative percent agreement for influenza A virus detection were 100.0% and 96.3%, respectively. There were no positive results for the influenza B virus or SARS-CoV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The cobas 6800 system and cobas SARS-CoV-2 &amp; Influenza A\/B showed high accuracy for influenza A virus detection and can be useful for clinical laboratories, especially those that routinely assay many samples.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-022-01916-w","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T07:03:38Z","timestamp":1668582218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical evaluation of a fully automated and high-throughput molecular testing system for detection of influenza virus"],"prefix":"10.1186","volume":"19","author":[{"given":"Kosuke","family":"Kosai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"issue":"10095","key":"1916_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","volume":"390","author":"C Paules","year":"2017","unstructured":"Paules C, Subbarao K. Influenza. Lancet. 2017;390(10095):697\u2013708.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1916_CR2","doi-asserted-by":"publisher","first-page":"A6","DOI":"10.1016\/j.vaccine.2020.09.048","volume":"39","author":"AE Macias","year":"2021","unstructured":"Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, et al. The disease burden of influenza beyond respiratory illness. Vaccine. 2021;39(Suppl 1):A6\u201314.","journal-title":"Vaccine"},{"issue":"7","key":"1916_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.7326\/0003-4819-156-7-201204030-00403","volume":"156","author":"C Chartrand","year":"2012","unstructured":"Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012;156(7):500\u201311.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1916_CR4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jiac.2021.01.010","volume":"27","author":"N Kaku","year":"2021","unstructured":"Kaku N, Kodama H, Akamatsu N, Ota K, Kosai K, Morinaga Y, et al. Multicenter evaluation of molecular point-of-care testing and digital immunoassays for influenza virus A\/B and respiratory syncytial virus in patients with influenza-like illness. J Infect Chemother. 2021;27(6):820\u20135.","journal-title":"J Infect Chemother"},{"issue":"1","key":"1916_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1373\/clinchem.2019.304782","volume":"66","author":"GT Hansen","year":"2020","unstructured":"Hansen GT. Point-of-care testing in microbiology: A mechanism for improving patient outcomes. Clin Chem. 2020;66(1):124\u201337.","journal-title":"Clin Chem"},{"key":"1916_CR6","doi-asserted-by":"crossref","unstructured":"Rezaei M, Razavi Bazaz S, Zhand S, Sayyadi N, Jin D, Stewart MP, et al. Point of care diagnostics in the age of COVID-19. Diagnostics. 2020;11(1).","DOI":"10.3390\/diagnostics11010009"},{"key":"1916_CR7","doi-asserted-by":"crossref","unstructured":"Norz D, Hoffmann A, Aepfelbacher M, Pfefferle S, Lutgehetmann M. Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A\/B detection on a high-throughput platform. J Med Microbiol. 2021;70(2).","DOI":"10.1099\/jmm.0.001295"},{"issue":"3","key":"1916_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/irv.12824","volume":"15","author":"T Chotpitayasunondh","year":"2021","unstructured":"Chotpitayasunondh T, Fischer TK, Heraud JM, Hurt AC, Monto AS, Osterhaus A, et al. Influenza and COVID-19: What does co-existence mean? Influenza Other Respir Viruses. 2021;15(3):407\u201312.","journal-title":"Influenza Other Respir Viruses"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01916-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-022-01916-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01916-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T07:03:42Z","timestamp":1668582222000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-022-01916-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1916"],"URL":"https:\/\/doi.org\/10.1186\/s12985-022-01916-w","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"7 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Nagasaki University Hospital (approval number:20111620).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Assays in this study were carried out by Roche Diagnostics K.K. K.Y. received honoraria from Roche Diagnostics K.K. M.H. is an employee of Roche Diagnostics K.K. Funding was provided by Roche Diagnostics K.K.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}